Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.
about
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesTelomere and Telomerase Therapeutics in CancerHuman Specific Regulation of the Telomerase Reverse Transcriptase GeneThe NF-κB Pathway and Cancer Stem CellsReactivation of telomerase in cancerIKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targetsThe ETS family of oncogenic transcription factors in solid tumours.Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promotersPhosphoprotein network analysis of white adipose tissues unveils deregulated pathways in response to high-fat diet.Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expressionActivation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali BurnAssociation of TERT promoter mutations with telomerase expression in melanoma.Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC.Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons.Current Insights to Regulation and Role of Telomerase in Human Diseases.Treating Cancer by Targeting Telomeres and Telomerase.Understanding TERT Promoter Mutations: A Common Path to Immortality.An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.Contemporary and potential future molecular diagnosis of melanoma.Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes.TERT promoter mutations in melanoma survival.Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status.Ikk2 regulates cytokinesis during vertebrate development.Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT.TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.Functional dissection of breast cancer risk-associated TERT promoter variants.TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.NFκB drives TERT promoter reactivation in cancer.ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression.Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma.Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma.Stabilization of NF-κB-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia.Insights about genome function from spatial organization of the genome.Multispectral optoacoustic and MRI coregistration for molecular imaging of orthotopic model of human glioblastoma.
P2860
Q26739925-14AD4257-69D2-45DF-B8D2-CC3B404F7455Q26744271-94932E03-67A2-4C74-B400-850D15A2B6F9Q26744808-BD762570-415F-4D57-9FA3-A165436BFFAAQ26745549-18F5E1EF-FA02-445F-9F41-808F6F2904C3Q26750605-5A2255AF-DADE-43D8-883A-FA7100FBACF4Q26769014-8838F71C-33C8-4C3B-85DE-C1120512D1ADQ33276239-6F0A69F9-2DF6-457D-B713-681F21765990Q33566723-AC29DCB1-18AD-4E95-B6DE-D8A102CA3FA3Q34555986-99A3E98A-FCE1-45B6-8346-3CE5F83F6583Q36221232-FED8A5B0-00BB-4CBC-8979-179749557B84Q36857933-A5000F84-D20B-4911-956D-3FC3D3044603Q36903098-27640B83-B359-46BA-B046-AF9B0A27861BQ37395716-D448873E-2440-44F5-BF1C-418865B68AE5Q37514988-B5F31694-7659-4396-A864-0085A07E89E8Q37595322-5B40F624-7567-458B-BB0B-D73774618479Q37596033-DF8F231B-C080-4C63-A55B-152553BFFBEDQ37607116-CD530D77-6ADE-404F-A335-4A5C3D531224Q37678884-9BD2A87B-2B47-4891-8CD0-C5CE269B2F21Q37741228-3F3D3624-FB64-4886-85C6-57907F8F35E7Q38288984-D61283F6-FDF0-4CB1-9A2F-1972F61F3BA7Q38760235-ADF885CA-42AA-4248-B9F2-E8D721EE2BD4Q38820649-6F1CDE35-8415-4C07-8612-C26B7E8C7925Q38838144-91DD8B6A-1C90-4392-9EDA-C3F6365748D9Q38847989-C8299F8D-F75F-4E44-B653-2C4B09F0D61FQ38998990-28A65B95-54D8-45DE-BDA7-D9AD5BA30762Q39111698-A82C527E-DE0F-4484-8D6E-D0BC5AB7504BQ39998496-1F9D9A2F-5983-449C-A9FC-E4BE2C84612DQ41342863-AEBBFC8B-F342-4C5D-947F-CAE282468825Q41387328-87610B23-7C72-4801-B7C2-B6EA859A4802Q42016940-3E20772D-662D-4F1D-80CE-407AB2FE6C8BQ42324664-2438C42E-5DBC-479D-9DEF-0584672A4B91Q42366538-33692521-3BA7-4B5A-AE76-F19582AC9B4EQ42748231-C335BC87-8821-477D-A317-7376FE4BD88FQ42910096-02075BD1-E195-46DB-9D20-707CCC3C8C67Q47224965-3E3D5D3A-8C58-4B6E-A18D-E09066E4F1F7Q47418685-F0CBBCFF-D821-477E-853D-5E3664BAFB03Q47916801-72114BE2-96E9-4730-8B16-AC8C8354E2E1Q49216080-700A0296-C77E-40BC-9F3E-A589EA6F3290Q49843050-EC15F757-7172-4F7C-B6FF-05CADB8960BDQ52139277-B5542B16-583B-4CAF-9173-BB99641ED3FC
P2860
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@ast
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@en
type
label
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@ast
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@en
prefLabel
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@ast
Non-canonical NF-κB signalling ...... tant TERT promoter activation.
@en
P2093
P2860
P356
P1433
P1476
Non-canonical NF-κB signalling ...... utant TERT promoter activation
@en
P2093
Anandhkumar Raju
Daniel G Tenen
Hui Shan Cheng
Manikandan Lakshmanan
Mengfeng Li
Qi-Ling Zhou
Shi-Yuan Cheng
Shyam Prabhakar
Vinay Tergaonkar
P2860
P2888
P304
P356
10.1038/NCB3240
P577
2015-09-21T00:00:00Z